MiR-564 functions as a tumor suppressor in human lung cancer by targeting ZIC3

被引:29
作者
Yang, Bin [1 ]
Jia, Lin [2 ]
Guo, Qiaojuan [3 ]
Ren, Hui [1 ]
Hu, Desheng [1 ]
Zhou, Xiaoyi [1 ]
Ren, Qingrong [1 ]
Hu, Yanping [1 ]
Xie, Tao [4 ]
机构
[1] Hubei Canc Hosp, Dept Oncol, Wuhan 430079, Hubei, Peoples R China
[2] Cent Hosp Wuhan, Dept Nephrol, Wuhan 430079, Hubei, Peoples R China
[3] Fujian Med Univ, Prov Clin Coll, Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou 350000, Fujian, Peoples R China
[4] Hubei Canc Hosp, Dept Radiat Oncol, Wuhan 430079, Hubei, Peoples R China
关键词
miR-564; ZIC3; Proliferation; Invasion; Tumor suppressor; Lung cancer; LYMPH-NODE METASTASIS; EXPRESSION; GENE; EPIDEMIOLOGY; CARCINOMA; ONCOGENE;
D O I
10.1016/j.bbrc.2015.10.082
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although miR-564 was reported to be dysregulated in human malignancy, the function and mechanism of miR-564 in tumorigenesis remains unknown. In the present study, we found that miR-564 frequently downregulated in lung cancer cells and significantly inhibited cell proliferation, cell cycle progression, motility, and the tumorigenicity of lung cancer cells. Moreover, we identified zic family member 3 (ZIC3) as a direct target of miR-564. ZIC3 overexpression impaired the suppressive effects of miR-564 on the capacity of lung cancer cells for proliferation and motility. Finally, we detected the expression level of miR-564 and ZIC3 protein in tissue specimens, and found a significant negative correlation between them. Patients with low levels of miR-564 showed a poorer overall survival. Taken together, our present study revealed the tumor suppressor role of miR-564, indicating restoration of miR-564 as a potential therapeutic strategy for the treatment of lung cancer. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:690 / 696
页数:7
相关论文
共 19 条
  • [1] MicroRNA history: Discovery, recent applications, and next frontiers
    Almeida, Maria I.
    Reis, Rui M.
    Calin, George A.
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2011, 717 (1-2) : 1 - 8
  • [2] Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray
    Bidus, MA
    Risinger, JI
    Chandramouli, GVR
    Dainty, LA
    Litzi, TJ
    Berchuck, A
    Barrett, JC
    Maxwell, GL
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (01) : 83 - 88
  • [3] Garzon R, 2009, ANNU REV MED, V60, P167, DOI [10.1146/annurev.med.59.053006.104707, 10.1146/annurev.pathol.4.110807.092222]
  • [4] He J, 2012, CHINESE CANC REGISTR
  • [5] A microRNA polycistron as a potential human oncogene
    He, L
    Thomson, JM
    Hemann, MT
    Hernando-Monge, E
    Mu, D
    Goodson, S
    Powers, S
    Cordon-Cardo, C
    Lowe, SW
    Hannon, GJ
    Hammond, SM
    [J]. NATURE, 2005, 435 (7043) : 828 - 833
  • [6] Molecular origins of cancer: Lung cancer
    Herbst, Roy S.
    Heymach, John V.
    Lippman, Scott M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) : 1367 - 1380
  • [7] Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2
    Inaguma, Shingo
    Ito, Hideaki
    Riku, Miho
    Ikeda, Hiroshi
    Kasai, Kenji
    [J]. ONCOTARGET, 2015, 6 (29) : 28257 - 28268
  • [8] The widespread regulation of microRNA biogenesis, function and decay
    Krol, Jacek
    Loedige, Inga
    Filipowicz, Witold
    [J]. NATURE REVIEWS GENETICS, 2010, 11 (09) : 597 - 610
  • [9] Impaired microRNA processing enhances cellular transformation and tumorigenesis
    Kumar, Madhu S.
    Lu, Jun
    Mercer, Kim L.
    Golub, Todd R.
    Jacks, Tyler
    [J]. NATURE GENETICS, 2007, 39 (05) : 673 - 677
  • [10] National survey of non-small cell lung cancer in the United States: Epidemiology, pathology and patterns of care
    Little, Alex G.
    Gay, E. Greer
    Gaspar, Laurie E.
    Stewart, Andrew K.
    [J]. LUNG CANCER, 2007, 57 (03) : 253 - 260